Targeted FVIII expression under the control of its native promoter for hemophilia A gene and cell therapy

被引：0
|
作者：
Zanolini, D. [1 ]
Merlin, S. [1 ]
Fama, R. [1 ]
Borroni, E. [1 ]
Bruscaggin, V. [1 ]
Zucchelli, S. [1 ]
Follenzi, A. [1 ]
机构：
[1] Univ Piemonte Orientale, Vercelli, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P331
引用
收藏
页码：A147 / A147
页数：1
相关论文
共 50 条
  • [1] Targeted FVIII Expression Under the Control of Its Native Promoter for Hemophilia A Gene and Cell Therapy
    Fama, Rosella
    Merlin, Simone
    Borroni, Ester
    Bruscaggin, Valentina
    Zucchelli, Silvia
    Follenzi, Antonia
    MOLECULAR THERAPY, 2017, 25 (05) : 302 - 302
  • [2] Transgene expression under the control of FVIII promoter for hemophilia A targeted therapy
    Zanolini, D.
    Merlin, S.
    Bruscaggin, V
    Follenzi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 134 - 134
  • [3] Targeting transgene expression under the control of FVIII promoter: determining the identity of FVIII producing cells for gene therapy of Hemophilia A
    Zanolini, Diego
    Merlin, Simone
    Bruscaggin, Valentina
    Follenzi, Antonia
    HUMAN GENE THERAPY, 2014, 25 (11) : A70 - A70
  • [4] Cell-specific FVIII expression in hemophilia A gene therapy to overcome immunological responses
    Merlin, S.
    Cannizzo, E. S.
    Bruscaggin, V
    Bellofatto, K.
    Follenzi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 253 - 253
  • [5] Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
    Jin Jea Sung
    Chul-Yong Park
    Joong Woo Leem
    Myung Soo Cho
    Dong-Wook Kim
    Experimental & Molecular Medicine, 2019, 51 : 1 - 9
  • [6] Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
    Sung, Jin Jea
    Park, Chul-Yong
    Leem, Joong Woo
    Cho, Myung Soo
    Kim, Dong-Wook
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (4): : 1 - 9
  • [7] Targeting FVIII expression to specific cell-types to overcome immunological responses for Hemophilia A gene therapy
    Merlin, S.
    Cannizzo, E. S.
    Bruscaggin, V.
    Follenzi, A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A38 - A39
  • [8] Targeting FVIII expression in endothelial and myeloid cells for hemophilia A gene therapy in mice
    Merlin, S.
    Cannizzo, E. S.
    Borroni, E.
    Bruscaggin, V.
    Valente, G.
    Prat, M.
    Arruda, V. R.
    Follenzi, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A154 - A154
  • [9] Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A
    Cai, Yuanhua
    Shi, Qizhen
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] FVIII expression driven by its native promoter allowed phenotypic correction in hemophilic mice
    Merlin, S.
    Fama, R.
    Borroni, E.
    Bruscaggin, V.
    Scardellato, S.
    Zanolini, D.
    Zucchelli, S.
    Follenzi, A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A166 - A167
12345